跳至主要内容
临床试验/CTRI/2026/02/103738
CTRI/2026/02/103738尚未招募不适用

A Clinical Study To Assess The Usefulness Of Causation In Homoeopathic Prescription In The Management Of Patients Suffering From Chronic Urticaria With Homoeopathic Remedies

Dr Amit Kumar1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年2月25日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To evaluate the effect of Individualized homoeopathic medicine based on causation in the management of Chronic Urticaria using Urticaria Activity Score over 7 days(UAS7) before and after the treatment

研究概览

简要总结

Chronic urticaria is a common, relapsing dermatological condition characterized by the presence of recurrent wheals, itching, and occasional angioedema, significantly affecting the quality of life of patients. Identification of causative factors plays an important role in the homoeopathic system of medicine, as causation is considered a key element in individualizing the prescription and selecting the most appropriate remedy.

The present study is planned to assess the usefulness of causation in homoeopathic prescription in the management of patients suffering from chronic urticaria. Patients fulfilling the inclusion and exclusion criteria will be enrolled from the outpatient department. Detailed case taking will be carried out with special emphasis on eliciting causative factors, and individualized homoeopathic medicines will be prescribed accordingly.

The effectiveness of the treatment will be evaluated using the Urticaria Activity Score over 7 days (UAS7) to assess disease activity, along with the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) to evaluate the impact of the disease and its treatment on patients’ quality of life. Assessment will be done at baseline, after 3 months, and at 6 months to observe changes in the severity and frequency of urticarial symptoms as well as quality of life parameters. The findings of the study are expected to provide clinical evidence regarding the role of causation in homoeopathic prescribing for chronic urticaria.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • •1.Patients clinically diagnosed with chronic urticaria.
  • •2.Participants of any gender, including male, female, and transgender individuals, will be eligible for the study.
  • •3.Patients belonging to the age group 18 years to 65 years.
  • •4.Literate patients who can read English or Hindi will be included.
  • •5.Illiterate patients will also be enrolled, and investigators will assist them in completing the questionnaires or scales while ensuring adequate privacy.
  • •6.Participants who will provide informed consent, comply with the study protocols, and attend all scheduled follow-up visits.

排除标准

  • •1.Patients suffering from severe systemic illnesses or any other life-threatening conditions.
  • •2.Patients with a history of severe anaphylactic shock.
  • •3.Pregnant and lactating women.
  • •4.Patients who refuse to give informed consent and not willing to come for follow ups.

结局指标

主要结局

To evaluate the effect of Individualized homoeopathic medicine based on causation in the management of Chronic Urticaria using Urticaria Activity Score over 7 days(UAS7) before and after the treatment

时间窗: 12 weeks to 24 weeks

次要结局

  • To evaluate the changes in the quality of life of patients suffering from chronic urticaria using Chronic Urticaria Quality of Life Questionnaire(CU-Q2oL)(12 weeks to 24 weeks)

研究者

发起方
Dr Amit Kumar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Amit Kumar

State National Homoeopathic Medical College and Hospital

研究点 (1)

Loading locations...

相似试验